NexImmune, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
NexImmune, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
- NexImmune, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.18M, a 442% increase year-over-year.
- NexImmune, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.01M, a 5.63% increase year-over-year.
- NexImmune, Inc. annual Nonoperating Income (Expense) for 2023 was $629K, a 9.11% increase from 2022.
- NexImmune, Inc. annual Nonoperating Income (Expense) for 2022 was $577K, a 75.5% decline from 2021.
- NexImmune, Inc. annual Nonoperating Income (Expense) for 2021 was $2.35M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)